Skip to main content

Published locations for AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy

User login

  • Reset your password
  • /content/aml-risk-doubled-low-risk-thyroid-cancer-patients-unnecessarily-given-radioactive-iodine
  • /hematologynews/article/147394/aml/aml-risk-doubled-low-risk-thyroid-cancer-patients-unnecessarily
  • /oncologypractice/article/147394/aml/aml-risk-doubled-low-risk-thyroid-cancer-patients-unnecessarily
  • /clinicalendocrinologynews/article/147394/aml/aml-risk-doubled-low-risk-thyroid-cancer-patients
  • /hematology-oncology/article/147394/aml/aml-risk-doubled-low-risk-thyroid-cancer-patients
  • /endocrinology/article/147394/aml/aml-risk-doubled-low-risk-thyroid-cancer-patients-unnecessarily